NCT04932577 - Fecal microbiota transplantation (FMT) & Liver Fibrosis / Cirrhosis

Study overview

It is a randomized clinical phase II/III treatment trial studying Fecal microbiota transplantation (FMT) or placebo in patients with Liver Fibrosis / Cirrhosis

Primary outcome measures

Time to death or new episode of acute decompensation requiring intervention in FMT versus placebo-treated patients

Results

There are no published results available for NCT04932577 as of April 2026